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A B S T R A C T
A prospective study of infective endocarditis (IE) was conducted between 1994 and 2000 in Marseilles,
France, and included 170 definite cases diagnosed with the use of modified Duke criteria. Classification
of IE based on the aetiological agent was related to epidemiological characteristics, including age,
gender and the nature of the injured valve. Enterococci and Streptococcus bovis were identified more
frequently in older subjects (p 0.02), and S. bovis was also associated with mitral valve infection (p 0.03).
Streptococcus spp. were found to be associated with native valves (p < 10)3), whereas coagulase-negative
staphylococci and Coxiella burnetii were associated with intracardiac prosthetic material (p < 0.05).
S. bovis and Staphylococcus aureus were the predominant species associated with presumably healthy
valves (p < 0.05), whereas oral streptococci caused IE exclusively in patients with previous valve
damage. The basic host status of IE patients has been linked to specific microorganisms, and this may be
of value when empirical treatment is needed in patients who have received previous antibiotic therapy
and whose blood cultures are negative.
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I N T R O D U C T I O N
Infective endocarditis (IE) remains a life-threat-
ening infection where an erroneous diagnosis
may lead to grave consequences. The clinical
manifestations of endocarditis are non-specific
and variable, and in many cases the diagnosis is
difficult. The diagnosis of IE is based on the
combination of fever, presence of a vegetation on
echocardiography, and positive blood cultures
[1]. However, absence of vegetations on echocar-
diography, or negative blood cultures and lack of
fever, do not exclude IE. Diagnostic criteria have
been proposed to help clinicians define cases of IE
[2,3]. The Duke criteria [2] or modified Duke
criteria [4–6] are used widely and allow cases to
be classified as definite or possible IE.
A classification of IE based on the aetiological
agent in association with characteristics that
include age, gender and nature of the injured
valve has been proposed previously [7–9]. How-
ever, clinical features, epidemiological parame-
ters, diagnostic evaluation and therapeutic
approaches are changing and necessitate period-
ical revision of the classifications [10]. The first
description of IE was in young subjects suffering
from rheumatic valvular disease. Then, older
patients with underlying heart disease were
reported. Subsequently, other forms have
emerged: IE in intravenous drug users (IDUs),
nosocomial endocarditis, or endocarditis linked
with new therapeutic modalities (e.g., prosthetic
valves, intravenous catheters, pacemakers and
dialysis shunts). Previous investigators have
defined the clinical specificity of IE in relation to
the aetiological agents in different categories of
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subjects, e.g., in male vs. female patients, or in
elderly vs. younger patients [11,12], in IDUs [13],
in subjects with prosthetic vs. native valves [14],
and in pacemaker carriers [15,16]. In the present
study, the prevalence of specific IE pathogens in
relation to the different categories of subjects (age,
gender, nature of the injured valve) are presented
in order to evaluate the specificity of the host–
bacteria relationship and its possible conse-
quences for patient management.
M A T E R I A L S A N D M E T H O D S
This prospective study was conducted in university hospitals
in Marseilles, France (Timone, Nord, Conception and Sainte
Marguerite Hospitals). These four hospitals were in different
areas of the city and were controlled by the same administra-
tive authorities. Each patient (‡ 18 years) with a suspected
diagnosis of IE between January 1994 and June 2000 was
investigated. Informed consent was obtained from each
patient. For each case, clinical data were collected by use of a
standardised questionnaire: sociodemographic data (age, gen-
der), type of the cardiac lesion (location of the lesion, nature of
the valve, presence of implanted material), and aetiological
agents. A distinction was made between cases involving
presumably healthy valves (PHVs) (patients without valvul-
opathy history), damaged native valves (DNVs) (patients with
a known valve lesion), and patients carrying intracardiac
material (ICM) (including pacemakers, and mechanical and
biological valves).
Transoesophageal echocardiography was performed by
experienced physicians. A standardised diagnostic kit for the
microbiological diagnosis of IE was used for each patient,
containing a sampling device along with written sampling
guidelines. The kit comprised three components. The first
component, to be used for immediate sampling, contained a
set of two blood culture vials, one for aerobic and one for
anaerobic cultures (BACTEC; Becton Dickinson, Sparks, MD,
USA), a lithium heparin vacutainer tube for culture of
intracellular bacteria, and a serum specimen sample in a
vacutainer tube for detection of rheumatoid factor and for the
serological diagnosis of Coxiella burnetii, Bartonella spp., Bru-
cella spp., Chlamydia spp., Mycoplasma pneumoniae, Legionella
pneumophila and Aspergillus spp. The second component, to be
used after a further 2 h, contained a set of two regular blood
culture vials and two vials containing resin. The third
component, to be used after a further 4 h, contained a set of
two blood culture vials.
Bacterial identification was according to standard proce-
dures [17]. When the routine test results were inconclusive,
PCR amplification was used, followed by sequencing of the
16S rRNA gene [18–20]. When surgical treatment was indica-
ted, valve samples, tissue fragments, abscess debridement and
vegetations were analysed histologically by a pathologist.
The Duke criteria [2] were applied to all suspected IE
patients. Cases presented in this study belonged to the definite
clinical criteria group. Seven groups of causative microorgan-
isms were identified: Streptococcus bovis, group A b-haemolytic
streptococci, oral streptococci, Enterococcus spp., Staphylococcus
aureus, coagulase-negative staphylococci (CNS) and C. burnetii.
Diagnosis of C. burnetii infection was based on serology. In
addition, two further groups were designated as: (1) other
microorganisms, including all the uncommon species; and (2)
culture-negative IE, when all microbiological tests were neg-
ative. The distribution of the causative agents was analysed
according to age, gender and valve characteristics. These study
groups were arranged to contain more than ten patients.
All data were stored and analysed by means of Epi-Info v.
6.0.4 software (CDC, Atlanta, GA, USA) and SPSS for Win-
dows (SPSS, Chicago, IL, USA). Descriptive statistics were
calculated, including means, standard deviations for continu-
ous variables, and frequencies for qualitative variables. Chi-
square or Fisher’s tests were used to compare qualitative
variables, and Student’s tests were used to compare quantita-
tive variables. The level of significance was set at p 0.05.
R E S U L T S
General features
During the study period, 168 consecutive patients
presented with 170 definite IE episodes defined
according to the Duke clinical criteria. The median
age was 65 years (range: 18–92 years), with a
male:female ratio of 2.8. Thirty-nine patients were
managed in a surgical unit, and 129 in a medical
unit. Underlying conditions identified were diabe-
tes (n ¼ 25), cancer (n ¼ 14), steroid therapy
(n ¼ 5), intravenous drug use (n ¼ 5), positive
HIV status (n ¼ 2), homelessness (n ¼ 2), and
dialysis (n ¼ 1). The lesion involved a native valve
in 90 (53%) cases and a prosthetic valve in 69 (41%)
cases. Aortic valves (n ¼ 97) and mitral valves
(n ¼ 83) were the foci of infection, while at least two
valves were involved in 28 cases. In ten cases, the
infection was related to pacemaker implantation.
Streptococci were the most common agents
(39%), followed by staphylococci (20%) (Table 1).
Among the 33 Strep. bovis cases, 20 were associ-
ated with a gastrointestinal source (polyp or
cancer). Methicillin resistance was observed in
two CNS cases (n ¼ 12) and in one S. aureus case
(n ¼ 22). Enterococci and C. burnetii were isolated
in 10% and 9.4% of cases, respectively. The 16
C. burnetii cases were all proven serologically, and
in ten cases were also identified by valve culture.
Eighteen cases were assigned to the other organ-
isms category (Table 2), and 19 cases were clas-
sified as culture-negative.
When the causative agents of IE were com-
pared between the age groups, no significant
differences were noted, except for the pooled
enteric cocci (enterococci and Strep. bovis), which
were identified more frequently in subjects aged
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> 65 years (p 0.02) (Table 3). No significant dif-
ferences were observed among pathogens when
gender was considered.
Involved valve and causative microorganisms
Strep. bovis was associated more frequently with
mitral valve infection (p 0.03), whereas CNS were
associated negatively with mitral valve infections
(p 0.02) (Table 3). The occurrence of microorgan-
isms on the aortic valve was non-specific, and
S. aureus was associated negatively with aortic
valves (p < 0.01).
IE cases were associated either with native
valves (53%) or ICM (47%). Streptococci were
associated frequently with native valves (70%;
p < 10)3), while CNS and C. burnetii were associ-
ated with ICM (83% and 73%, respectively;
p < 0.05) (Table 4).
PHVs constituted 39% of the affected native
valves. Strep. bovis infected these valves preferen-
tially (60%), whereas oral streptococci infected
DNVs exclusively (Table 4). Two CNS cases were
connected with DNVs (although this was not a
significant association). Strep. bovis and S. aureus
were associated significantly with PHVs
(p < 0.05).
Among patients with a previous history of
either a native or prosthetic valve lesion, the only
significant difference in associated aetiological
agents between the two groups was for Strepto-
coccus spp., which were involved more frequently
with DNVs. Among prosthetic valve infections,
CNS were associated significantly with artificial
valves rather than with biological valves (five vs.
two, p 0.02; Table 4).
Table 5 shows different clinical situations and
the frequency of isolation of the microorganisms,
grouped according to the subcategories of
Table 2. Causative agents classified under other microor-
ganisms (n ¼ 18).
n
HACEK groupa 4
Streptococcus pneumoniae 3
Bartonella quintana 2
Haemophilus parainfluenzae 1
Neisseria sicca 1
Campylobacter fetus 1
Acinetobacter baumannii 1
Escherichia coli 1
Micrococcus 1
Corynebacterium diphtheriae 1
Propionibacterium acnes 1
Candida spp. 1
aHaemophilus (n ¼ 2), Actinobacillus (n ¼ 2), Capnocytophaga, Eikenella, Kingella
group.
Table 3. Age, gender and location of the cardiac lesion and associated microorganisms
Age groups (years) Gender Mitral lesion Aortic lesion
< 65 ‡ 65 pa Female Male pa Yes No pa Yes No pa
Streptococcus spp. 30 35 NS 18 48 NS 36 30 NS 42 24 NS
Strep. bovis 13 20 NS 6 27 NS 22 11 0.03 18 15 NS
Oral streptococci 16 14 NS 11 19 NS 14 16 NS 21 9 NS
b-Haemolytic streptococci 1 2 NS 1 2 NS 0 3 NS 3 0 NS
Enterococcus spp. 5 12 NS 5 12 NS 8 9 NS 12 5 NS
Staphylococcus spp. 19 15 NS 9 25 NS 12 22 NS 15 19 NS
S. aureus 15 7 NS 7 15 NS 10 12 NS 7 15 0.009
CNS 4 8 NS 2 10 NS 2 10 0.02 8 4 NS
Coxiella burnetii 11 5 NS 3 13 NS 7 9 NS 9 7 NS
Other microorganisms 10 8 NS 3 15 NS 9 9 NS 12 6 NS
Negative 9 10 NS 7 12 NS 11 8 NS 8 11 NS
Total 84 85 45 125 83 86 97 72
Strep. bovis
and Enterococcus spp.
18 32 0.02 11 39 NS 30 20 NS 30 20 NS
ap: chi-square or Fisher’s tests (tests measured between one species and the rest of the cases).
CNS, coagulase-negative staphylococci.
NS, not significant.
Table 1. Causative agents of the 170 cases of infective
endocarditis
n %
Streptococcus spp.
Strep. bovis 33 19.4
Viridans streptococci 30 17.6
b-Haemolytic streptococci 3 1.8
Subtotal 66 38.8
Staphylococcus spp.
S. aureus 22 12.9
CNSa 12 7.1
Subtotal 34 20
Enterococcus spp.b 17 10
Coxiella burnetii 16 9.4
Other microorganisms 18 10.6
Negative IE 19 11.2
Total 170 100
aCNS, coagulase-negative staphylococci: S. epidermidis (n ¼ 9), S. capitis (n ¼ 1), S.
haemophilus (n ¼ 1), S. hominis (n ¼ 1).
bE. faecalis (n ¼ 10), E. faecium (n ¼ 1), E. durans (n ¼ 1), non-identified (n ¼ 5).
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patients as defined by interview (sex, age and
previous valvular history).
D I S C U S S I O N
The sociodemographic characteristics of the 170
definite IE cases in the present series were similar
to those in studies reported previously. Only
cases that were definite according to Duke criteria
were studied, and these represented only a
proportion of all endocarditis cases [13,21]. In
this series, the mean age was c. 60–65 years, and
there was a higher proportion of males. This
study differs from others in that there were fewer
IDUs and more cases involving C. burnetii, a
pathogen investigated specifically in Marseilles.
The proportions of patients with native and
prosthetic valves were similar to those in other
studies [9,13]. The proportion of tricuspid local-
isation of the IE lesion in this series was very low
compared with studies published in the USA,
where there was a high proportion of IDUs [22].
Two or more valves were injured in 16% of cases,
similar to the figure reported in another study
[22]. No differences were observed between
elderly and younger subjects with regard to the
location of the lesion, as reported previously [11].
The prevalence (20%) of IE cases caused by
Staphylococcus spp. was lower than that found in
other studies [9,13], but that of streptococci (39%)
was similar to that reported previously [3]. No
differences between the two age groups (younger
or older than 65 years) were observed in the
frequency of the causative agents, as reported in
other studies [11], except for the enteric cocci,
Enteroccoccus spp. and Strep. bovis (p < 0.01). As
reported previously [23], the commonest organ-
isms found in prosthetic valve endocarditis were
streptococci, in particular Strep. bovis, while Sta-
phylococcus spp. were second in frequency. In
other studies, staphylococci were found more
frequently [22,24,25]. This may be because of the
increased incidence of severe cases in referrals,
whereas cases caused by oral streptococci may be
treated safely in regional hospitals. In addition,
some other studies have reported only prosthetic
valve cases [26].
Blood cultures usually allow recovery of the
aetiological agent of IE, and are considered to be
the most important available laboratory diagnos-
tic tests. However, this approach fails to identify
some agents [27,28]. Culture-negative endocardi-
tis represents a real challenge for physicians
[29,30]. New techniques have been developed to
improve the diagnosis of blood culture-negative
endocarditis [1]. In the present study, systematic
investigation with use of a kit enabled identifica-
tion of some causative agents. For example, the
frequency of isolation of C. burnetii was 9%,
compared to other studies where no cases were
found [13,22,24], although Q fever endocarditis is
now established clearly as being responsible
for some cases of culture-negative endocarditis
[31–33]. Among the 16 patients diagnosed with Q
fever endocarditis, most were males (81%), and
young (69%), with ICM infection (69%) (Tables 3
and 4).
In the category of other organisms, Bartonella
was diagnosed by serological tests [34,35]. Its
incidence in blood culture-negative endocarditis
Table 4. Association between valve status and causative agent
NV ICM p* PHV Other p* PHV ICM p* ICM DNV p* MV BV p* PHV DNV p*
Streptococcus spp. 46 20 < 10–3 15 48 NS 15 20 0.05 20 28 0.001 5 13 NS 15 28 NS
Strep. bovis 23 10 0.05 13 19 0.002 13 10 0.002 10 9 NS 2 7 NS 13 9 0.05
Oral streptococci 21 9 0.04 0 28 0.003 0 9 0.03 9 19 < 10)3 3 6 NS 0 19 < 10)6
b-Haemolytic
streptococci
2 1 NS 2 1 NS 2 1 NS 1 0 NS 0 0 – 2 0 NS
Enterococcus spp. 7 10 NS 1 16 NS 1 10 NS 10 6 NS 2 6 NS 1 6 NS
Staphylococcus spp. 16 18 NS 10 24 NS 10 18 NS 18 6 NS 7 5 NS 10 6 0.03
S. aureus 14 8 NS 10 12 0.004 10 8 0.01 8 4 NS 2 3 NS 10 4 0.02
CNS 2 10 0.004 0 12 NS 0 10 0.02 10 2 NS 5 2 0.02 0 2 NS
Coxiella burnetii 4 11 0.03 0 15 0.03 0 11 0.02 11 4 NS 3 8 NS 0 4 NS
Other microorganisms 8 10 NS 3 15 NS 3 10 NS 10 5 NS 1 7 NS 3 5 NS
Negative 9 10 NS 5 14 NS 5 10 NS 10 4 NS 3 5 NS 5 4 NS
Total 90 79 34 132 34 79 79 53 21 44 34 53
Strep. bovis
and Enterococcus spp.
30 20 NS 14 35 NS 14 20 NS 20 15 NS 4 13 NS 14 15 NS
NV, native valve; ICM, intracardiac material; PHV, presumably healthy valve; DNV, damaged native valve; MV, mechanical valve; BV, biological valve; CNS, coagulase-
negative staphylococci; NS, not significant.
*p: chi-square or Fisher’s tests (tests measured between one species and the rest of the cases).
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ranges from 2% to 30%; the variation in fre-
quency may reflect inadequate laboratory tech-
niques, or less rigidly defined criteria for the
diagnosis of endocarditis [36,37]. The rate of
culture-negative endocarditis will certainly de-
crease with the systematic use of specific serology
in all cases of clinically suspected endocarditis,
and with the growing use of newer histological
and molecular tests on blood and tissue samples
[38]. In this population, the rate of culture-negat-
ive endocarditis was 11%, comparable to what
has been found in other studies [13,28], and
endocarditis was limited mainly to patients with
previous antibiotic treatment (data not shown).
A patient presenting with a putative diagnosis
of IE may have different suspected aetiologies,
depending on age, gender, and the presence or
absence of a known cardiac lesion. The analysis
shown in Table 5 could be used by a physician as
an indication of which microorganisms are likely
to be involved in each situation. For example, in a
70-year-old man with a native valve, the most
frequent pathogen responsible for IE was Strep.
bovis. Therefore, appropriate treatment and tar-
geted investigation, such as colonoscopy, should
probably be recommended, even when blood
cultures are negative. The data show that the
most frequent causative agents differed according
to host factors. Thus, Strep. bovis and S. aureus are
isolated most frequently from males aged
‡ 65 years with a PHV, whereas oral streptococci
and Enterococcus spp. are the organisms associ-
ated with DNVs. In the hospitals considered in
this study, C. burnetii was the most common
aetiological agent of endocarditis in males aged
< 65 years with a prosthetic valve; aortic involve-
ment also indicated this aetiology.
These data are currently restricted to a single
city, and therefore cannot be extrapolated to other
areas; however, the extension of this approach to
a large international database may make it
applicable more generally. IE is frequently des-
cribed according to the causative agent: classical
and easily identifiable agents, agents of blood
culture-negative endocarditis, fastidious agents,
or rare bacteria [1]. Our approach, based on easily
obtainable specific data such as gender, age, and
characteristics of the cardiac lesion, could be
useful in the diagnosis of IE, since it is very
similar to the reasoning of a physician when a
patient is examined for the first time. It is known
that repeat blood cultures represent the best T
a
b
le
5
.
M
ai
n
ca
u
sa
ti
v
e
ag
en
ts
ac
co
rd
in
g
to
h
o
st
st
at
u
s
N
V
P
H
V
D
N
V
IC
M
P
V
B
V
P
a
ce
m
a
k
er
M
it
ra
l
v
a
lv
e
A
o
rt
ic
v
a
lv
e
M
an ‡
65
y
ea
rs
1.
S
tr
ep
.
bo
vi
s
1.
S
tr
ep
.
bo
vi
s
O
ra
l
st
re
p
to
co
cc
i
1.
S
tr
ep
.
bo
vi
s
⁄
E
n
te
ro
co
cc
u
s
1.
S
tr
ep
.
bo
vi
s
⁄
E
n
te
ro
co
cc
u
s
1.
E
n
te
ro
co
cc
u
s
1.
S
tr
ep
.
au
re
u
s
⁄
C
N
S
1.
S
tr
ep
.
bo
vi
s
1.
S
tr
ep
.
bo
vi
s
2.
O
ra
l
st
re
p
to
co
cc
i
2.
S
.
au
re
u
s
2.
E
n
te
ro
co
cc
u
s
2.
S
.
au
re
u
s
2.
O
th
er
s
2.
S
tr
ep
.
bo
vi
s
⁄
o
th
er
s
2.
O
th
er
s
2.
O
ra
l
st
re
p
to
co
cc
i
2.
E
n
te
ro
co
cc
u
s
3.
E
n
te
ro
co
cc
u
s
3.
E
n
te
ro
co
cc
u
s
O
ra
l
st
re
p
to
co
cc
i
n
¼
57
n
¼
26
n
¼
12
n
¼
12
n
¼
30
n
¼
23
n
¼
16
n
¼
7
n
¼
23
n
¼
31
M
an <
65
y
ea
rs
1.
S
tr
ep
.
bo
vi
s
1.
S
tr
ep
.
bo
vi
s
⁄
S
.
au
re
u
s
1.
O
ra
l
st
re
p
to
co
cc
i
1.
C
.
bu
rn
et
ii
⁄
o
th
er
s
1.
C
.
bu
rn
et
ii
1.
C
.
bu
rn
et
ii
1.
b-
H
ae
m
o
ly
ti
c
st
re
p
to
co
cc
i
1.
S
tr
ep
.
bo
vi
s
1.
O
ra
l
st
re
p
to
co
cc
i
2.
O
ra
l
st
re
p
to
co
cc
i
2.
N
eg
at
iv
e
2.
S
tr
ep
.
bo
vi
s
2.
O
th
er
s
⁄
C
N
S
2.
O
th
er
s
2.
N
eg
at
iv
e
2.
O
th
er
s
⁄
S
.
au
re
u
s
2.
O
th
er
s
3.
S
.
au
re
u
s
3.
O
th
er
s
3.
O
ra
l
st
re
p
to
co
cc
i
3.
C
.
bu
rn
et
ii
n
¼
67
n
¼
42
n
¼
14
n
¼
27
n
¼
25
n
¼
23
n
¼
14
n
¼
2
n
¼
30
n
¼
44
W
o
m
an
>
65
y
ea
rs
1.
O
ra
l
st
re
p
to
co
cc
i
1.
O
ra
l
st
re
p
to
co
cc
i
1.
N
eg
at
iv
e
1.
N
eg
at
iv
e
1.
N
eg
at
iv
e
1.
N
eg
at
iv
e
1.
S
tr
ep
.
bo
vi
s
⁄
o
ra
l
st
re
p
to
co
cc
i
2.
S
tr
ep
.
bo
vi
s
2.
S
tr
ep
.
bo
vi
s
n
¼
28
n
¼
13
n
¼
4
n
¼
9
n
¼
15
n
¼
14
n
¼
9
n
¼
1
n
¼
19
n
¼
13
N
V
,
n
at
iv
e
v
al
v
e;
P
H
V
,
p
re
su
m
ab
ly
h
ea
lt
h
y
v
al
v
e;
D
N
V
,
d
am
ag
ed
n
at
iv
e
v
al
v
e;
IC
M
,
in
tr
ac
ar
d
ia
c
m
at
er
ia
l;
P
V
,
p
la
st
h
et
ic
v
al
u
e;
B
V
,
b
io
lo
g
ic
al
v
al
v
e;
C
N
S
,
co
ag
u
la
se
-n
eg
at
iv
e
st
ap
h
y
lo
co
cc
i.
306 Clinical Microbiology and Infection, Volume 10 Number 4, April 2004
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 302–308
approach to improving the chance of identifying
the causative agent. Nevertheless, physicians
analyse automatically the first available elements,
such as sex, age and underlying conditions, to
rank the possible aetiological agents and define
empirical therapy. This is particularly necessary
when antibiotic therapy is administered before
blood cultures are obtained, or when the first
results are negative. Rapid identification of the
aetiological agent is vital for successful manage-
ment of the patient. Van Scoy demonstrated that
patients who became afebrile in the first week of
antibiotic therapy survived longer than those who
were febrile after this time period [39]. The
present study describes the heterogeneity of the
aetiological agents in different age groups, there-
by helping in the choice of successful initial
therapy.
We believe that this approach for investigating
suspected IE cases (i.e., combining an exhaustive
collection of clinical data with a standardised
diagnostic kit for microbiological diagnosis and
echocardiography) should be confirmed in differ-
ent geographical regions and with different
patient populations. If it is found to be successful,
a global prospective validation study should be
conducted.
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